Retroperitoneal xanthogranuloma (xanthogranulomatous inflammation) is a rare inflammatory pseudotumor formed by lipid-laden macrophages (foamy cells). The most critical diagnostic feature of this disease is its fat-negative character: despite macrophages accumulating intracellular lipid, it does NOT show macroscopic fat density (<-30 HU) on CT because lipid is dispersed within cells and does not reach the low density of macroscopic fat tissue. This fat-negative feature is the basis of differentiation from liposarcoma and the most valuable diagnostic finding. On CT, it appears as a low-to-intermediate density (20-50 HU), heterogeneously enhancing mass. It is a benign pathology but may show locally invasive behavior and infiltrate surrounding tissues — this invasive behavior can mimic malignancy. It shares histopathological features with xanthogranulomatous pyelonephritis in the kidney, with lipid-laden macrophages (foamy cells) being the dominant cell population in both.
Age Range
30-70
Peak Age
50
Gender
Equal
Prevalence
Rare
Xanthogranuloma develops from chronic inflammatory process based on macrophage-mediated lipid phagocytosis. In areas of chronic inflammation or necrosis, macrophages become activated and phagocytize necrotic tissue, cell membrane remnants, and free lipids. Following phagocytosis, they accumulate large amounts of intracellular lipid → cytoplasm acquires foamy appearance and these cells are called 'foam cells.' However, this intracellular lipid does NOT show macroscopic fat density on CT — this critical distinction relies on the following physical mechanism: macroscopic fat tissue (adipose) consists of adipocytes with nearly pure triglyceride droplets (>95% lipid) intercellularly → low density (-50 to -120 HU). In xanthogranuloma, lipid is dispersed within macrophage cytoplasm (as membrane-bound vacuoles) mixed with cellular water, protein, and organelles → average density remains in positive HU range (20-50 HU). This 'fat-negative' character positions xanthogranuloma in the rare category of lipid-containing but macroscopic fat-negative lesions. The granulomatous reaction contains giant cells (Touton-type — multinucleated giant cells arranged around lipid droplets), lymphocytes, plasma cells, and fibrous tissue. Enhancement results from neovascularization in granulation tissue — inflammatory VEGF production creates new vessels that accumulate contrast. Locally invasive behavior results from inflammatory cytokines (TNF-alpha, IL-1, IL-6) causing diffuse infiltration into surrounding tissues, potentially mimicking malignancy.
Retroperitoneal mass NOT containing macroscopic fat (all voxels >0 HU on ROI) with inflammatory enhancement pattern — most distinguishing finding for xanthogranuloma separating it definitively from liposarcoma (macroscopic fat voxels <-30 HU present).
On contrast-enhanced CT, a low-to-intermediate density (20-50 HU), heterogeneously enhancing retroperitoneal mass. Does NOT contain macroscopic fat density (<-30 HU) — all voxels above 0 HU on ROI measurement. This fat-negative character is the key distinguishing finding from liposarcoma. Enhancement reflects neovascularization of granulation tissue with inflammatory pattern heterogeneity. May show infiltrative spread to surrounding tissues crossing fascial planes.
Report Sentence
A fat-negative (ROI: all voxels >0 HU) heterogeneously enhancing mass is seen in the retroperitoneal space; xanthogranulomatous process should be considered.
On T2, xanthogranuloma shows heterogeneous intermediate signal. Fibrous areas show low T2 (collagen → short T2), active inflammatory areas show high T2 (edema + cellular infiltration → long T2), foamy macrophage areas show intermediate T2. No significant signal loss expected on fat suppression because no macroscopic fat — intracellular lipid is not at concentration suppressible by chemical shift frequency.
Report Sentence
The mass shows heterogeneous intermediate T2 signal without significant signal loss on fat suppression; consistent with fat-negative inflammatory mass.
On T1, isointense to slightly hypointense signal to muscle. No macroscopic fat signal (T1 hyperintense + loss on fat suppression) — this is the most critical MRI finding for differentiating from liposarcoma. Absence of signal loss on chemical shift (opposed-phase) imaging also confirms macroscopic fat absence.
Report Sentence
The mass shows isointense signal to muscle on T1 without macroscopic fat signal or chemical shift signal loss.
Variable diffusion restriction may be seen on DWI — active inflammatory areas show moderate restriction (ADC 1.0-1.5 x 10⁻³ mm²/s). Fibrous areas show low cellular density → high ADC. ADC values are generally higher than malignant tumors (ADC <0.8) but lower than normal tissue (ADC >1.5) — this intermediate ADC profile is consistent with inflammatory mass.
Report Sentence
Variable moderate diffusion restriction is seen in the mass with ADC values higher than malignant tumors.
On non-contrast CT, dystrophic calcification may be seen in 20-30% of xanthogranulomas. Calcification pattern may be irregular, coarse, or punctate. Calcification is a marker of chronic inflammatory process reflecting calcium deposition in necrotic tissues. Calcification presence is consistent with benign inflammatory process.
Report Sentence
Dystrophic calcification foci are seen within the mass consistent with chronic inflammatory process.
On contrast-enhanced MRI, heterogeneous enhancement is seen — active inflammatory areas show intense enhancement while fibrous areas show low enhancement. Enhancement pattern reflects inflammatory neovascularization. Homogeneous intense enhancement is not expected (differs from solid tumor). Ring or peripheral enhancement pattern may be seen.
Report Sentence
Heterogeneous inflammatory enhancement pattern is seen on contrast-enhanced MRI.
Criteria
No known etiology, de novo development — idiopathic form
Distinct Features
Focal mass, minimal or no surrounding organ involvement; may be better circumscribed; diagnosis by biopsy and surgical resection usually curative
Criteria
Underlying etiology: retroperitoneal hemorrhage, surgery (postoperative), infection, foreign body reaction
Distinct Features
Location in area of prior pathology, correlation with clinical history important; post-hemorrhage hemosiderin-laden macrophages → xanthogranulomatous transformation; surgical material remnants (suture, clip) may trigger reaction in postoperative cases
Criteria
Diffuse retroperitoneal involvement, widespread infiltration rather than focal mass — retroperitoneal fibrosis-like presentation
Distinct Features
May resemble retroperitoneal fibrosis (periaortic/periureteral thickening); may require differential from IgG4-related disease; ureteral obstruction and hydronephrosis may develop; systemic steroid therapy may be effective in IgG4-related form
Distinguishing Feature
Leiomyosarcoma generally larger (>10 cm), more heterogeneous enhancement, prominent necrosis, and irregular margins; xanthogranuloma smaller, inflammatory pattern enhancement, minimal necrosis. Both may be fat-negative but leiomyosarcoma is SMA positive, xanthogranuloma is CD68 (macrophage marker) positive.
Distinguishing Feature
Erdheim-Chester disease (ECD) shows diffuse periaortic/perirenal infiltration ('coated aorta' sign) and bilateral osteosclerotic bone lesions; xanthogranuloma presents as focal mass without bone involvement. Both contain lipid-laden histiocytes but ECD is distinguished by BRAF V600E mutation.
Distinguishing Feature
Teratoma shows macroscopic fat + calcification + cyst triad (fat voxels <-30 HU on ROI); xanthogranuloma is fat-negative (all voxels >0 HU). Definitive differentiation by ROI densitometry.
Urgency
routineManagement
surgicalBiopsy
NeededFollow-up
6-monthDefinitive diagnosis is by biopsy because imaging findings are not specific and malignancy (especially liposarcoma and leiomyosarcoma) must be excluded. Histopathology shows foamy macrophages (CD68 positive, S-100 negative), Touton-type giant cells, lymphocytes, and fibrous tissue. Surgical resection is recommended for symptomatic or growing lesions; resection is usually curative with rare recurrence (5-10%). Conservative follow-up is an option for small asymptomatic lesions — serial imaging monitoring size and enhancement. Underlying etiology should be treated. Histopathological examination is mandatory for definitive differentiation from malignancy — imaging alone is not sufficient. If IgG4-related retroperitoneal fibrosis is in the differential, serum IgG4 level and tissue IgG4/IgG ratio should be evaluated; steroid therapy may be effective in IgG4-positive cases.
Xanthogranuloma is a benign condition but biopsy is mandatory as it mimics malignancy. Surgical resection or steroid therapy may be applied. The inflammatory process can compress adjacent organs (such as ureteral obstruction).